Jin-Yuan Chen
No ORCID on file
· 1 paper in corpus
· active 2026
Background Elagolix and Myfembree are gonadotropin-releasing hormone (GnRH)-pathway therapies used for endometriosis, but their post-marketing safety reporting patterns remain incompletely characterized. Because spontaneous reporting databa…